Related Experiment Video

Updated: Jun 24, 2026

Preparation of Cell-lines for Conditional Knockdown of Gene Expression and Measurement of the Knockdown Effects on E4orf4-Induced Cell Death
13:54

Preparation of Cell-lines for Conditional Knockdown of Gene Expression and Measurement of the Knockdown Effects on E4orf4-Induced Cell Death

Published on: October 21, 2012

Involvement of SRC-3 in deguelin-induced apoptosis in Jurkat cells

Rui Li1, Yan Chen, Wen-xiu Shu

  • 1Department of Hematology Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

International Journal of Hematology
|April 15, 2009
PubMed

Insights

Deguelin effectively inhibits leukemia cell growth by halting the cell cycle and inducing apoptosis. Its anticancer effects in Jurkat cells are linked to downregulating steroid receptor coactivator-3 (SRC-3) and nuclear factor-kappaB (NF-kappaB).

Area of Science:

  • Pharmacology
  • Molecular Biology
  • Cancer Research

Background:

  • Jurkat cells are a human T lymphocyte cell line commonly used in leukemia research.
  • Deguelin is a natural compound with potential anticancer properties.
  • Understanding the molecular mechanisms of deguelin's action is crucial for developing new leukemia therapies.

Purpose of the Study:

  • To investigate the anticancer effects of deguelin on Jurkat cells.
  • To elucidate the molecular mechanisms underlying deguelin's action, focusing on cell cycle, apoptosis, and key signaling pathways.

Main Methods:

  • Cell viability was assessed using MTT assay.
  • Apoptosis was detected by TUNEL assay and transmission electron microscopy.
  • Cell cycle distribution was analyzed via propidium iodide staining.
  • Gene and protein expression levels of SRC-3, NF-kappaB, Bcl-2, and Bcl-xL were determined by RT-PCR and Western blotting.

Main Results:

  • Deguelin inhibited Jurkat cell proliferation with a 24-h IC(50) of 43.73 +/- 0.35 nmol/L.
  • Deguelin induced cell-cycle arrest in the G(1)/G(0) phase and promoted apoptosis in Jurkat cells.
  • Deguelin treatment led to the downregulation of steroid receptor coactivator-3 (SRC-3) and nuclear factor-kappaB (NF-kappaB) expression.
  • The expression of apoptosis-related genes Bcl-2 and Bcl-xL was influenced by deguelin's effects on SRC-3 and NF-kappaB.

Conclusions:

  • Deguelin exhibits potent anticancer effects against Jurkat cells in vitro, characterized by growth arrest and apoptosis induction.
  • The antileukemia activity of deguelin is associated with the interruption of the SRC-3 signaling pathway.
  • Downregulation of SRC-3 and NF-kappaB contributes to deguelin-induced apoptosis by modulating Bcl-2 and Bcl-xL expression.

More Related Videos

Establishing Cell Lines Overexpressing DR3 to Assess the Apoptotic Response to Anti-mitotic Therapeutics12:28

Establishing Cell Lines Overexpressing DR3 to Assess the Apoptotic Response to Anti-mitotic Therapeutics

Published on: January 11, 2019

Related Concept Videos

The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Cellular Injury V: Apoptosis and Autophagy01:22

Cellular Injury V: Apoptosis and Autophagy

Cells respond to damage and stress through highly coordinated processes that decide whether they survive or undergo controlled self-destruction. Two major pathways involved in this regulation are apoptosis, a type of programmed cell death, and autophagy, a survival mechanism that helps cells adapt to adverse conditions.ApoptosisApoptosis removes aged or injured cells to maintain tissue balance. During this process, the cell shrinks, chromatin condenses and fragments, and membrane-bound...